auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Pharma Glycovax IncDepartment
National Research Council CanadaAmount
$8.1M
Province
QCType
Contribution
Agreement Number
172-2020-2021-Q2-957295
Purpose
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
Pharma Glycovax Inc × National Research Council Canada
10 grants totalling $53.6M
Industrial Research Assistance Program – Contributions to Firms
26,784 grants totalling $5.1B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| ILLUMIN INC. | $10.0M | Industrial Research Assistance Program –... |